Evidence map›Paper›PMID 24743155›Full record

Observational studyPloS one2014

A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.

Allison A Lambert, Gregory D Kirk, Jacquie Astemborski, Enid R Neptune, Shruti H Mehta, Robert A Wise, M Bradley Drummond

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Allison A LambertDepartment of Medicine, Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Maryland, United States of America.
Gregory D KirkDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, United States of America.
Jacquie AstemborskiDepartment of Epidemiology, Johns Hopkins University, Baltimore, Maryland, United States of America.
Enid R NeptuneDepartment of Medicine, Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Maryland, United States of America.
Shruti H MehtaDepartment of Epidemiology, Johns Hopkins University, Baltimore, Maryland, United States of America.
Robert A WiseDepartment of Medicine, Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Maryland, United States of America.
M Bradley DrummondDepartment of Medicine, Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Maryland, United States of America.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
Nutrition and Metabolism CoreP30DA013868 · NIDA · TUFTS UNIVERSITY BOSTON · PI GORBACH, SHERWOOD · 2002 to 2012
$10.0M
THE NATURAL HISTORY OF HIV INFECTION AMONG DRUG USERSR01DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 1987 to 2011
$7.6M
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)R01HL090483 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2007 to 2011
$4.4M
Immune Mechanisms of HIV-associated COPDU01HL121814 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D, MCDYER, JOHN F · 2013 to 2017
$3.5M
Mechanisms of COPD Subphenotype DevelopmentK23HL103192 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DRUMMOND, MICHAEL BRADLEY · 2010 to 2013
$650k
NHLBI NIH HHS K23 HL103192NHLBI NIH HHS K23HL103192NHLBI NIH HHS R01 HL090483NHLBI NIH HHS R01-HL-90483NHLBI NIH HHS T32 HL007534NHLBI NIH HHS U01 HL121814NIDA NIH HHS P30 DA013868NIDA NIH HHS R01 DA004334NIDA NIH HHS R01 DA012568NIDA NIH HHS R01-DA-04334NIDA NIH HHS R01-DA-12568NIDA NIH HHS U01 DA036297
6 · The paper itself

Abstract

backgroundVitamin D deficiency is associated with reduced lung function. Cathelicidin, an antimicrobial peptide regulated by vitamin D, plays a role within the innate immune system. The association of cathelicidin with lung function decrement and respiratory infection is undefined. We determined the independent relationship of cathelicidin with lung function.

methodsIn a cross-sectional analysis of 650 participants in an urban observational cohort with high smoking prevalence, plasma 25(OH)-vitamin D and cathelicidin levels were measured from stored samples obtained within 6 months of spirometry study visits. Multivariable linear regression was used to determine the independent association between low cathelicidin (defined as the lowest quartile of the cohort) and absolute forced expiratory volume in 1 second (FEV1).

resultsThe mean age of the cohort was 49 years; 91% were black, 35% female and 41% HIV-infected. Participants with low cathelicidin had a 183 mL lower FEV1 compared to higher cathelicidin (p = 0.009); this relationship was maintained (115 ml lower; p = 0.035) after adjusting for demographics, BMI, and smoking. Neither HIV serostatus, heavy smoking history, nor 25(OH)-vitamin D levels were associated with cathelicidin levels. Participants with low cathelicidin had a greater prevalence of prior bacterial pneumonia (21% versus 14%; p = 0.047). Inclusion of pneumonia in adjusted models did not substantially reduce the FEV1 decrement observed with low cathelicidin (104 mL lower FEV1; p = 0.05). Lung function decrements associated with low cathelicidin were greatest among individuals with lower 25(OH)-vitamin D levels.

conclusionsIn a cohort at risk for airflow obstruction, low cathelicidin was independently associated with lower FEV1. These clinical data support a mechanistic link between 25(OH)-vitamin D deficiency and lung function impairment, independent of pneumonia risk.

Indexed as

Antimicrobial Cationic PeptidesForced Expiratory VolumeLungVitamin D DeficiencyAdultCathelicidinsCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedSmokingVitamin D25-hydroxyvitamin DAntimicrobial Cationic PeptidesCathelicidinsVitamin D

Identifiers

PMID24743155
PMCPMC3990590
OpenAlexW1969049820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.